Videos
My bookmarks
My bookmarks
Expo HubTheranostics journey

Jordan’s theranostics journey

Follow Jordan on his prostate cancer journey

1Key statistics for prostate cancer: Prostate cancer facts. Prostate Cancer Facts | American Cancer Society. (n.d.). Available at https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html#:~:text=About%201%20in%2044%20men,point%20are%20still%20alive%20today. 
2Novartis. Understanding Metastatic Castration-Resistant Prostate Cancer. Available at https://www.us.pluvicto.com/about-metastatic-castration-resistant-prostate-cancer/understanding-metastatic-prostate-cancer/. 
3Data courtesy of Rome Imaging Center, Rome, Georgia, USA.
4Products and features mentioned herein are not commercially available in all countries. Future availability cannot be guaranteed.
5Novartis. FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer. Available at https://www.novartis.com/news/media-releases/fda-approves-novartis-radioligand-therapy-pluvicto-earlier-use-chemotherapy-psma-positive-metastatic-castration-resistant-prostate-cancer.
6Data courtesy of Nebraska Cancer Specialists, Omaha, Nebraska, USA.
7Data courtesy of Osaka City University Hospital, Osaka, Japan.
8Every Symbia Pro.specta configuration produces the highest image quality in its class. Based on competitive literature available at time of publication. Data on file.
You are entering a global domain of Siemens Healthineers.

If you choose to continue, please note that information in this domain is meant to be generic and country-independent. The devices displayed or mentioned may not be commercially available in all countries and their future availability cannot be guaranteed.

Continue

All EventsVideosShape SpotlightCorporate websiteHealthcare professionalsFAQSubscribe to our newsletterJobs & Careers